Drawing for PERFERO

USPTO serial 99862675

PERFERO

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
SHOOR, AMIT KUMAR
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PERFERO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leesa N. Weiss

Leesa N. Weiss Edell, Shapiro & Finnan, LLC401 North Washington StreetSuite 801Rockville, MD 20850

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated skin care preparations for the care of skin, hair, and scalp issues related to female health conditions, namely, hormone related conditions in the nature of acne and thyroid related skin, hair, and scalp conditions; Non-medicated skin care preparations for the care of skin, hair, and scalp issues related to female health conditions, namely, hormone related symptoms related to menopause and perimenopause; Non-medicated skin care preparations; Non-medicated hair and nail care preparationsACTIVE—
005Pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal conditions; Pharmaceutical preparations and substances for the prevention and treatment of podiatric conditions; Pharmaceutical preparations and substances for the prevention and treatment of dermatologic conditions; pharmaceutical preparations for treating skin disorders; anti-inflammatory preparations; topical anti-fungal steroid preparations; pharmaceutical preparations for the care of skin, hair, and scalp issues related to female health conditions, namely, hormone related conditions in the nature of acne and thyroid related skin, hair, and scalp conditions; pharmaceutical preparations for the care of skin, hair, and scalp issues related to female health conditions, namely, hormone related symptoms related to menopause and perimenopauseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 11, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 14, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 14, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 14, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 13, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 13, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 13, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 7, 2026DOCKASSIGNED TO EXAMINER—
Oct 6, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 3, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 3, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance